List of Tables
Table 1. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anaplastic Lymphoma Kinase ALK Inhibitor Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anaplastic Lymphoma Kinase ALK Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anaplastic Lymphoma Kinase ALK Inhibitor, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anaplastic Lymphoma Kinase ALK Inhibitor, Product Type & Application
Table 12. Global Key Manufacturers of Anaplastic Lymphoma Kinase ALK Inhibitor, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anaplastic Lymphoma Kinase ALK Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anaplastic Lymphoma Kinase ALK Inhibitor as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Region (2020-2025) & (K Units)
Table 18. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Region (2020-2025)
Table 19. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Region (2026-2031) & (K Units)
Table 20. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Region (2026-2031)
Table 21. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Region (2020-2025)
Table 23. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Region (2026-2031)
Table 25. North America Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Country (2020-2025) & (K Units)
Table 27. North America Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Country (2026-2031) & (K Units)
Table 28. North America Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anaplastic Lymphoma Kinase ALK Inhibitor Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anaplastic Lymphoma Kinase ALK Inhibitor Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units) by Type (2020-2025)
Table 51. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units) by Type (2026-2031)
Table 52. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Type (2020-2025)
Table 53. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Type (2026-2031)
Table 54. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Type (2020-2025)
Table 57. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Type (2026-2031)
Table 58. Global Anaplastic Lymphoma Kinase ALK Inhibitor Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anaplastic Lymphoma Kinase ALK Inhibitor Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units) by Application (2020-2025)
Table 61. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units) by Application (2026-2031)
Table 62. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Application (2020-2025)
Table 63. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Application (2026-2031)
Table 64. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Application (2020-2025)
Table 67. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Application (2026-2031)
Table 68. Global Anaplastic Lymphoma Kinase ALK Inhibitor Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anaplastic Lymphoma Kinase ALK Inhibitor Price (US$/Unit) by Application (2026-2031)
Table 70. Astellas Pharma Company Information
Table 71. Astellas Pharma Description and Business Overview
Table 72. Astellas Pharma Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Astellas Pharma Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 74. Astellas Pharma Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AstraZeneca Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Betta Pharmaceuticals Company Information
Table 81. Betta Pharmaceuticals Description and Business Overview
Table 82. Betta Pharmaceuticals Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Betta Pharmaceuticals Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 84. Betta Pharmaceuticals Recent Developments/Updates
Table 85. GlaxoSmithKline Company Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. GlaxoSmithKline Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Merck Company Information
Table 91. Merck Description and Business Overview
Table 92. Merck Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Merck Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 94. Merck Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Novartis Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 99. Novartis Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Pfizer Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Roche Company Information
Table 106. Roche Description and Business Overview
Table 107. Roche Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Roche Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 109. Roche Recent Developments/Updates
Table 110. Takeda Pharmaceuticals Company Information
Table 111. Takeda Pharmaceuticals Description and Business Overview
Table 112. Takeda Pharmaceuticals Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Takeda Pharmaceuticals Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 114. Takeda Pharmaceuticals Recent Developments/Updates
Table 115. Turning Point Therapeutics Company Information
Table 116. Turning Point Therapeutics Description and Business Overview
Table 117. Turning Point Therapeutics Anaplastic Lymphoma Kinase ALK Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Turning Point Therapeutics Anaplastic Lymphoma Kinase ALK Inhibitor Product
Table 119. Turning Point Therapeutics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Anaplastic Lymphoma Kinase ALK Inhibitor Distributors List
Table 123. Anaplastic Lymphoma Kinase ALK Inhibitor Customers List
Table 124. Anaplastic Lymphoma Kinase ALK Inhibitor Market Trends
Table 125. Anaplastic Lymphoma Kinase ALK Inhibitor Market Drivers
Table 126. Anaplastic Lymphoma Kinase ALK Inhibitor Market Challenges
Table 127. Anaplastic Lymphoma Kinase ALK Inhibitor Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anaplastic Lymphoma Kinase ALK Inhibitor
Figure 2. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Share by Type: 2024 & 2031
Figure 4. First Generation ALK Inhibitor Product Picture
Figure 5. Second Generation ALK Inhibitor Product Picture
Figure 6. Third Generation ALK Inhibitor Product Picture
Figure 7. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Share by Application: 2024 & 2031
Figure 9. Hospital Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Others
Figure 12. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Size (2020-2031) & (US$ Million)
Figure 14. Global Anaplastic Lymphoma Kinase ALK Inhibitor Sales (2020-2031) & (K Units)
Figure 15. Global Anaplastic Lymphoma Kinase ALK Inhibitor Average Price (US$/Unit) & (2020-2031)
Figure 16. Anaplastic Lymphoma Kinase ALK Inhibitor Report Years Considered
Figure 17. Anaplastic Lymphoma Kinase ALK Inhibitor Sales Share by Manufacturers in 2024
Figure 18. Global Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Anaplastic Lymphoma Kinase ALK Inhibitor Players: Market Share by Revenue in Anaplastic Lymphoma Kinase ALK Inhibitor in 2024
Figure 20. Anaplastic Lymphoma Kinase ALK Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Anaplastic Lymphoma Kinase ALK Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Country (2020-2031)
Figure 23. North America Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Country (2020-2031)
Figure 24. United States Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Country (2020-2031)
Figure 27. Europe Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Country (2020-2031)
Figure 28. Germany Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Region (2020-2031)
Figure 35. China Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Country (2020-2031)
Figure 45. Latin America Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Anaplastic Lymphoma Kinase ALK Inhibitor Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Anaplastic Lymphoma Kinase ALK Inhibitor Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Anaplastic Lymphoma Kinase ALK Inhibitor by Type (2020-2031)
Figure 55. Global Revenue Market Share of Anaplastic Lymphoma Kinase ALK Inhibitor by Type (2020-2031)
Figure 56. Global Anaplastic Lymphoma Kinase ALK Inhibitor Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Anaplastic Lymphoma Kinase ALK Inhibitor by Application (2020-2031)
Figure 58. Global Revenue Market Share of Anaplastic Lymphoma Kinase ALK Inhibitor by Application (2020-2031)
Figure 59. Global Anaplastic Lymphoma Kinase ALK Inhibitor Price (US$/Unit) by Application (2020-2031)
Figure 60. Anaplastic Lymphoma Kinase ALK Inhibitor Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
